C-Suite Access is Earned

And never expected

Why outreach alone will not get you in the room, and the three strategies that will.

If I had to name the single most common frustration I hear from sales leaders and individual contributors, it would be this one: I cannot get a meeting with the C-suite. I have called, I have emailed, I have followed up, and nothing is working.

I hear it every week. It comes from reps selling clinical products, capital equipment, services, software, consulting. It comes from founders trying to close enterprise health systems. It comes from seasoned account executives who have been hitting quota for years and suddenly cannot crack a specific account.

So let me put a stake in the ground, because this is the foundation of everything I teach about selling to hospitals.

Access is earned. It is never expected.

That one sentence will change the way you build your pipeline if you let it. The frustration most sellers carry is built on a quiet assumption: that outreach should be enough. That because you sent a thoughtful email, or left a polite voicemail, or made a LinkedIn connection, a meeting should follow. It will not. And it should not.

Hospital executives are not withholding meetings because they are difficult. They are withholding meetings because there are not enough hours in their day to take one that does not move their priorities forward. The CFO has a multi-billion-dollar budget, payer negotiations, capital decisions in motion, and a board to answer to. The COO is solving for throughput and labor. The CMO is balancing quality, safety, and physician relationships. None of them owe you their time. They will give it to you if, and only if, you have earned it.

So the question becomes simple, and it is the one I want you to sit with: what does value actually look like, defined from their seat, not yours?

Why “value” has quietly stopped meaning value

Most sales training in our industry teaches you to lead with the same three buckets: reduce cost, increase revenue, reduce risk. Those are true. They are also, at this point, generic.

The most common move I see reps make in the name of value is sending a case study. I love a good case study. They have their place. But pause and think about it from the executive’s side of the table.

Right now, this week, that executive’s inbox is full of case studies. Every rep is sending one. When everyone leads with the same proof point, the proof point stops working. Worse, a generic case study sent cold signals something the sender probably does not intend to communicate. It signals that the conversation is about the vendor, not the executive. It is transactional. The executive can feel it.

So if generic case studies, broad ROI claims, and templated outreach are not the path, what is?

There are 3 out of the 8 strategies I coach my clients on. Let me take them one at a time.

Strategy one: lead with a unique insight about their hospital, not your solution

This is the strategy that separates the rep who gets the meeting from the rep who keeps following up.

A unique insight is not a stat you pulled from Google or a generative AI summary of the industry. It is your own thinking, applied specifically to the hospital you are trying to reach, drawing on data and experience the executive themselves may not have stitched together.

Here is a concrete example. Say your service is operational improvement in the OR. The generic version of your pitch is, “We help hospitals improve OR throughput, and our clients have seen meaningful gains.” That gets a polite no.

Now compare that to this. You pull the executive’s Medicare Cost Report. You go into surgical line profitability by DRG. You look at DRG 470 or DRG 475, cross-reference against two other publicly available data sets, and you build a one-page executive brief that says: based on three publicly reported data points, here is what we are seeing inside your DRG 475 profile, here are the three areas with the most room to improve, and here is what that improvement is plausibly worth.

Let me show in detail what I mean:

Leveraging Medicare Cost Reports and Public Data for DRG-Level Profitability Outreach

By triangulating data from the Medicare Cost Report (HCRIS), the CMS Inpatient Prospective Payment System (IPPS) Final Rule Impact File, and the MedPAR dataset, you can construct a highly credible, data-driven narrative. This approach moves the conversation from a vendor pitch to a peer-level financial review.

The Three Pillars of Public Data

To build a compelling executive brief, you must synthesize three distinct but complementary datasets:

1. The Medicare Cost Report (HCRIS)

The Healthcare Provider Cost Reporting Information System (HCRIS) contains the annual Medicare Cost Reports submitted by all Medicare-certified hospitals. This is the foundational document for understanding a hospital’s true cost structure, beyond what they charge.

Key Worksheets for Surgical Profitability:

• Worksheet A: This worksheet maps the hospital’s trial balance expenses to specific Medicare cost centers. It shows the raw, unallocated costs for departments like the Operating Room (Line 50), Medical Supplies Charged to Patients (Line 71), and Implantable Devices Charged to Patients (Line 72).

• Worksheet C, Part I: This is arguably the most critical worksheet for profitability analysis. It calculates the Cost-to-Charge Ratio (CCR) for each ancillary department. By dividing total costs by total charges, the CCR allows you to convert a hospital’s gross charges on a patient claim into an estimated actual cost. For surgical lines, you will look specifically at the CCRs for the Operating Room and Implantable Devices.

• Worksheet D-1: This worksheet computes the inpatient operating cost. It provides the average cost per diem for routine care (e.g., Med/Surg beds, ICU). When combined with the length of stay for a specific DRG, this allows you to estimate the routine room and board costs for those patients.

2. The CMS IPPS Final Rule Impact File and Tables

Published annually, the IPPS Final Rule dictates how Medicare pays for inpatient stays. The associated data tables provide the payment parameters for every DRG.

Key Data Elements:

• Relative Weight: Each DRG is assigned a relative weight that reflects the average resources required to treat patients in that group compared to the average Medicare case. For example, DRG 470 has a specific relative weight that, when multiplied by the hospital’s base payment rate, determines the base reimbursement.

• Geometric Mean Length of Stay (GMLOS): The IPPS tables publish the national geometric mean length of stay for each DRG. This serves as a critical benchmark. If a target hospital’s average LOS for DRG 470 is 3.5 days, but the national GMLOS is 2.2 days, that variance represents a quantifiable margin leak.

3. The MedPAR Dataset

The Medicare Provider Analysis and Review (MedPAR) file contains claim-level data for all Medicare Part A inpatient discharges. While the raw file is massive, aggregated MedPAR data (often available through secondary analytics platforms or CMS public use files) provides hospital-specific performance metrics by DRG.

Key Data Elements:

• Average Total Charges by DRG: The average amount the hospital billed for DRG 470 or 475.

• Average Medicare Payment by DRG: The actual average reimbursement received.

• Average Length of Stay by DRG: The hospital’s actual average LOS for that specific procedure.

The Analytical Methodology: Connecting the Dots

To build the executive brief, you must connect the data from these three sources to estimate the hospital’s true margin on a specific DRG.

1. Determine the Revenue: Use MedPAR data to find the hospital’s average Medicare payment for DRG 470.

2. Estimate the Costs:

◦ Take the hospital’s average total charges for DRG 470 (from MedPAR).

◦ Apply the hospital’s overall or department-specific Cost-to-Charge Ratios (from HCRIS Worksheet C) to those charges to estimate the true cost of the case.

◦ Pro-Tip: For orthopedic and spinal procedures, isolate the implant charges and apply the specific CCR for “Implantable Devices Charged to Patients” (Worksheet C, Line 72). This often reveals that high implant costs are destroying the margin.

3. Calculate the Margin: Subtract the estimated true cost from the average Medicare payment.

4. Identify the Variance: Compare the hospital’s estimated cost and actual Length of Stay against the national averages (from the IPPS Final Rule tables).

The One-Page Executive Brief Template

This template is designed to be sent directly to a hospital CFO or VP of Finance. It uses their own data to highlight a specific financial vulnerability and proposes a targeted discussion.

CONFIDENTIAL EXECUTIVE BRIEFING Prepared For:

[Executive Name], [Title], [Hospital Name] Subject: Margin Variance Analysis: Surgical Service Line (MS-DRG 470 & 475) Date: [Date]

Executive Summary Based on an analysis of [Hospital Name]’s most recent Medicare Cost Report (FY [Year]) and CMS MedPAR claims data, we have identified a significant margin compression within your high-volume orthopedic and spinal surgical lines, specifically MS-DRG 470 (Major Joint Replacement) and MS-DRG 475.

While these procedures represent a critical revenue stream, your facility is currently underperforming national benchmarks in cost-to-serve and length of stay, resulting in an estimated margin leak of $[X.XX]M annually on Medicare volume alone.

Data-Driven Observations (Based on Publicly Reported Data)

1. Implant Cost Variance (HCRIS Worksheet C, Line 72) Your Cost-to-Charge Ratio (CCR) for Implantable Devices is currently [X.XX]. When applied to your average implant charges for DRG 470, your estimated implant cost per case is $[X,XXX]. This is [X]% higher than the regional average of $[X,XXX]. This suggests an immediate opportunity for vendor contract renegotiation or physician preference item (PPI) standardization.

2. Length of Stay (LOS) Drag (MedPAR vs. IPPS Final Rule) According to recent MedPAR data, your average Length of Stay for DRG 470 is [X.X] days. The CMS Geometric Mean Length of Stay (GMLOS) for this DRG is [X.X] days. This [X.X] day variance, when multiplied by your routine per diem cost of $[X,XXX] (derived from HCRIS Worksheet D-1), represents an excess cost of $[X,XXX] per discharge.

3. Operating Room Efficiency (HCRIS Worksheet A & C, Line 50) Your Operating Room cost center shows a fully allocated cost per minute that exceeds peer facilities of similar size and acuity. This indicates potential bottlenecks in OR turnover times or over-allocation of overhead, compressing the margin on fixed-reimbursement DRGs.

The Financial Impact By closing the gap to the 50th percentile benchmark in just two areas—Implant Costs and Length of Stay—[Hospital Name] could realize an estimated margin improvement of $[X,XXX] per Medicare discharge for DRG 470. Across your annual Medicare volume of [X] cases, this represents a $[X.XX]M bottom-line opportunity.

Proposed Next Steps: This analysis is based on publicly available CMS data. We have developed a proprietary methodology to help facilities like [Hospital Name] capture these specific margin opportunities without disrupting clinical workflows.

If you are open to a further discussion on our strategies, lets schedule a call to review the underlying data model and discuss how we may be able to provide our O.R. financial improvement strategies to your hospital.

That is not a pitch. That is consulting.

And it gives the executive something none of your competitors are giving them: thinking that is specific to their hospital.

I hear the objection all the time: “if I give it away, they will take the brief and ignore me.”

First, they are already ignoring you, so the downside is zero.

Second, they will not.

Their reaction is going to be the opposite. They are going to think, if this is what they put in a one-page brief I did not even ask for, what would they bring to a working conversation? What would they bring as my advisor? What would they bring if I were actually using their product or service? That is the line of thought that opens the calendar.

Strategy two: publish original content only you could have written

The second way to earn access is to be visible in the market with original thinking that no one else can replicate.

I am not talking about a fluffy blog post that any AI tool could generate in ninety seconds. I am talking about real intellectual work. A quarterly industry review on a topic you own. A point of view on a CMS policy shift, with the implications spelled out. An original research piece pulled from your customer interviews and your team’s collective field intelligence.

The test is simple. Could a generalist sit down and produce the same piece in an afternoon? If yes, you have not built a moat. The piece you want to produce is one where the answer is no. It is the piece authorities and associations start citing because it is the cleanest articulation of a problem they have all been trying to name. It is the piece an executive forwards to a colleague and says, I want us to think about this.

That kind of content earns access on autopilot, because executives reach out to the author. You become a known voice on a specific topic, and the meeting requests start coming the other direction.

Strategy three: show up differently in how you reach out

The third move is more tactical, and it amplifies the first two. Most outreach looks identical: same templated email, same LinkedIn message, same cadence. So when something different lands in the executive’s inbox, they notice.

A short asynchronous video is one way to do this. Thirty seconds, looking into the camera: I put together a one-page brief specific to your hospital and your surgical service line. I would like to send it over. Would that be useful? That is a very different ask than “do you have 15 minutes next week.” You are not asking for time. You are offering value, and asking permission to deliver it.

Another version is a no-charge executive brief delivered to the team. Thirty minutes, on a specific topic that matters to them, no pitch attached. Hospitals appreciate this when the content is genuinely useful, and it gives you a chance to meet the team in a low-pressure setting where you are the one giving, not asking.

One more variation that works well: send the executive a piece of original content you have written and ask for their feedback. Not a pitch. A genuine ask: I put this together, and I would value your perspective. Is there anything you would add, change, or push back on? Executives respect people who are willing to be edited, and it positions you as a peer, not a vendor.

In all three tactics, the through line is the same. You are not asking for access. You are demonstrating, in advance and in concrete form, the kind of value you would bring once the relationship existed.

The bigger picture

Marc Benioff has said for years that every meaningful enterprise deal Salesforce closed in its early growth years involved the CEO. Not procurement. Not the line manager. The CEO. That is not a vanity statistic. It is a discipline. Salesforce built a motion that earned that level of access on every important deal.

You can build the same motion. It does not replace what you already use. If your team runs Challenger, MEDDIC, or Miller Heiman, keep them. They are good. Layer on top of them a C-suite selling discipline that treats access as something earned through unique insight, original content, and differentiated outreach.

That is the missing layer. When my clients install it, the results are not incremental. They are material.

So the next time you feel the frustration of a quiet inbox, do not ask why they are not responding. Ask the harder question: what have I given them that would make a response inevitable?

That is where the work is. And that is where the meetings are.

———

For a conversation about building a stronger C-Suite strategy inside your company, reach me directly at lisa@lisatmiller.com